Table 3.
Postoperative parameters
| Value | BHM group | CRM group | P value | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Postoperative seroma |
Yes 13 (46.4%) |
No 15 (53.6%) |
Yes 9 (20.9%) |
No 34 (79.1%) |
0.08 | ||||||
| Seroma localisation | |||||||||||
| Subcutaneous | 9 (69.2%) | 5 (55.6%) | 0.54 | ||||||||
| Under the mesh | 4 (30.8%) | 4 (44.4%) | |||||||||
| Seroma therapy | |||||||||||
| None | 5 (38.5%) | 4 (44.4%) | 0.43 | ||||||||
| Drainage | 4 (30.8%) | 5 (55.6%) | |||||||||
| Operative | 4 (30.8%) | 0 (0%) | |||||||||
| Operative revision | 8 (28.6%) | 20 (71.4%) | 7 (16.3%) | 36 (83.7%) | 0.22 | ||||||
| Hernia recurrence after 24 month follow-up | 1 (3.6%) | 27 (96.4%) | 12 (28.9%) | 31 (72.1%) | 0.03* | ||||||
| Duration till recurrence, median (IQR), months | 5 | 10 (1–22) | 0.39 | ||||||||
| Actual pain |
Yes 4 (14.3%) |
No 21 (75%) |
Unknown 3 (10.7%) |
Yes 3 (7%) |
No 33 (76.7%) |
Unknown 7 (16.3%) |
0.21 | ||||
| VAS-Score | 4 (3–6) | 4 (3–6) | 1.0 | ||||||||
| Ability to work |
Yes 12 (42.9%) |
No 10 (35.7%) |
Unknown 6 (21.4%) |
Yes 19 (44.2%) |
No 16 (37.2%) |
Unknown 8 (18.6%) |
0.83 | ||||
*Hernia recurrence rate after 24 months is significant lower in the BHM group (CI 0.95)